Amid its various efforts to provide Covid-19 tests, Abbott Laboratories (ABT) claims to have encountered a new problem: a key employee in its diagnostics business unexpectedly resigned last month to take a job with a rival company and planned to take trade secrets with him, according to a lawsuit.
In arguing its case, Abbott maintained that Jerome Clavel, a global marketing executive who was primarily responsible for rapid diagnostic tests for infectious diseases in emerging markets, told his boss and a human resources representative that he was resigning for his health and did not have another job lined up.
About the Author Reprints
